300
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery

, , , , , , , , , , , & show all
Pages 1697-1708 | Published online: 28 Mar 2012

References

  • HortobágyiGNAnthracyclines in the treatment of cancer: an overviewDrugs199754Suppl 417
  • GoodmanMFLeeGMAdriamycin interactions with T4 DNA polymerase: two modes of template-mediated inhibitionJ Biol Chem1977252826702674323251
  • GehlJBoesgaardMPaaskeTVittrup JensenBDombernowskyPCombined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxicAnn Oncol1996776876938905026
  • YousefpourPAtyabiFFarahaniEVSakhtianchiRDinarvandRPolyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluationsInt J Nanomedicine201161487149621796249
  • KangYMKimGHKimJIIn vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymerBiomaterials201132204556456421440935
  • GaoZGLeeDHKimDIBaeYHDoxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in miceJ Drug Target200513739139716308207
  • WeinbergBDAiHBlancoEAndersonJMGaoJAntitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirodsJ Biomed Mater Res A200781116117017120197
  • ChenYWanYWangYZhangHJiaoZAnticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticlesInt J Nanomedicine201162321232622072869
  • Al-AbdAMHongKYSongSCKuhHJPharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing miceJ Control Release2010142110110719819274
  • XieMZhouLHuTYaoMIntratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenograftsAnticancer Drugs200718445946617351398
  • EmerichDFSnodgrassPLafreniereDSustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusionsPharm Res20021971052106012180539
  • ChangGTLiCLuWYDingJDN-Boc-histidine-capped PLGA-PEG- PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pHMacromol Biosci201010101248125620593367
  • XuXLChenXSWangZFJingXBUltrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicityEur J Pharm Biopharm2009721182519027067
  • XieJHuangJLiXSunSChenXIron oxide nanoparticle platform for biomedical applicationsCurr Med Chem200916101278129419355885
  • ChenBChengJShenMMagnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
  • WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
  • NeubergerTSchopfBHofmannHHofmannMvon RechenbergBSuperparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery systemJ Magn Magn Mater20052931483496
  • ArrueboMFernández-PachecoRIbarraMRSantamaríaJMagnetic nanoparticles for drug deliveryNano Today2007232232
  • McBainSCYiuHHDobsonJMagnetic nanoparticles for gene and drug deliveryInt J Nanomedicine20083216918018686777
  • WidderKJMorrisRMPooreGHowardDPJrSenyeiAETumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicinProc Natl Acad Sci U S A19817815795816941258
  • LübbeASBergemannCHuhntWPreclinical experiences with magnetic drug targeting: tolerance and efficacyCancer Res19965620469447018840986
  • LübbeASBergemannCRiessHClinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumorsCancer Res19965620468646938840985
  • AlexiouCJurgonsRSchmidRJMagnetic drug targeting–biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatmentJ Drug Target200311313914913129824
  • ChariRVTargeted cancer therapy: conferring specificity to cytotoxic drugsAcc Chem Res20084119810717705444
  • MurakamiTTsuchidaKHashidaMImahoriHSize control of lipid-based drug carrier by drug loadingMol Biosyst20106578979120567763
  • PatilRRGuhagarkarSADevarajanPVEngineered nanocarriers of doxorubicin: a current updateCrit Rev Ther Drug Carrier Syst200825116118540835
  • KataokaKMatsumotoTYokoyamaMDoxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significanceJ Control Release2000641–314315310640653
  • SpringateCMJacksonJKGleaveMEBurtHMClusterin antisense complexed with chitosan for controlled intratumoral deliveryInt J Pharm20083501–2536417890029
  • GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
  • ChoiHSLiuWMisraPRenal clearance of quantum dotsNat Biotechnol200725101165117017891134
  • ChoulyCPouliquenDLucetIJeuneJJJalletPDevelopment of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistributionJ Microencapsul19961332452558860681
  • GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
  • YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release200068341943110974396
  • StubbsMMcSheehyPMGriffithsJRBashfordCLCauses and consequences of tumour acidity and implications for treatmentMol Med Today200061151910637570
  • TannockIFRotinDAcid pH in tumors and its potential for therapeutic exploitationCancer Res19894916437343842545340
  • WangHZhaoYWuYEnhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesBiomaterials201132328281829021807411
  • DesaiMPLabhasetwarVWalterELevyRJAmidonGLThe mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependentPharm Res19971411156815739434276
  • PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
  • JordanAScholzRSchnoyNWustPMaier-HauffKFelixRDifferential endocytosis of magnetic fluid particles into human primary glioblastoma, neuronal and fibroblast cells in vitroEur J Cell Biol1997Suppl 4732
  • WeisslederRKellyKSunEYShtatlandTJosephsonLCell-specific targeting of nanoparticles by multivalent attachment of small moleculesNat Biotechnol200523111418142316244656
  • KohlerNSunCWangJZhangMMethotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cellsLangmuir200521198858886416142971
  • HuangXTengXChenDTangFHeJThe effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell functionBiomaterials201031343844819800115
  • KohlerNSunCFichtenholtzAGunnJFangCZhangMMethotrexate- immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug deliverySmall20062678579217193123
  • ChenBChengJWuYReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-miceInt J Nanomedicine20094737819421372
  • JiangZChenBAXiaGHThe reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsInt J Nanomedicine2009410711419516889
  • WidderKJSenyeiAERanneyDFIn vitro release of biologically active Adriamycin by magnetically responsive albumin microspheresCancer Res19804010351235177438037
  • GuptaPKHungCTMagnetically controlled targeted chemotherapyWillmottNDalyJMicrospheres and Regional Cancer TherapyBoca Raton, FLCRC Press199371116